Successful Treatment of Syndrome of Inappropriate Antidiuretic Hormone Secretion Associated with Neuro-Sweet Disease in Myelodysplastic Syndrome

Intern Med. 2018 Feb 15;57(4):595-600. doi: 10.2169/internalmedicine.9215-17. Epub 2017 Dec 8.

Abstract

Sweet disease may occur in several organs, and central nervous system involvement, known as Neuro-Sweet disease (NSD), is rare. The clinical features of NSD include recurrent encephalomeningitis accompanied by fever and erythematous plaques; systemic corticosteroid therapy is highly effective. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is an important electrolyte abnormality because it can be life-threatening. We describe the first case of SIADH and NSD associated with low-risk myelodysplastic syndrome that was successfully treated with corticosteroids and cyclosporine. The patient has remained stable for 1 year without any recurrence.

Keywords: Neuro-Sweet disease (NSD); myelodysplastic syndrome (MDS); syndrome of inappropriate antidiuretic hormone secretion (SIADH).

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Inflammatory Agents / therapeutic use*
  • Cyclosporine / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Inappropriate ADH Syndrome / diagnosis
  • Inappropriate ADH Syndrome / drug therapy*
  • Inappropriate ADH Syndrome / etiology
  • Myelodysplastic Syndromes / complications*
  • Prednisolone / therapeutic use*
  • Sweet Syndrome / complications*
  • Sweet Syndrome / diagnosis

Substances

  • Anti-Inflammatory Agents
  • Immunosuppressive Agents
  • Cyclosporine
  • Prednisolone